Key facts
- nVoq’s last known valuation is $81.9M (Jul 2021).
- It has raised $95.7M; the latest was Later Stage VC ($750K) in Sep 2025.
- Notable investors include Shay Houser, Steve Tran.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for nVoq
- ·The full record, as it builds
Funding rounds
No funding rounds for nVoq are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About nVoq
Developer of a cloud-based speech recognition platform designed to transform clinical documentation processes for in-home healthcare and hospice care. The company's platform features HIPAA-compliant, real-time speech-to-text conversion with APIs for integration, medically specialised vocabularies, and compatibility with electronic health records and business applications, enabling healthcare providers to improve documentation accuracy, reduce administrative time, and support revenue protection and clinician retention in post-acute care settings.
- Sector
- Healthcare
- HQ
- Boulder, CO, United States
- Founded
- 2000
- Employees
- 65
- Website
- nvoq.com/
- Ownership
- Privately Held (backing)
nVoq doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in nVoq shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on nVoq in its N-PORT filings yet. We sweep new filings monthly.